Attributes | Values |
---|
rdf:type
| |
Description
| - V této práci byla metoda SPR porovnána s metodou ELISA pro přímou a amplifikovanou detekci perspektivního biomárkru rakoviny – CD166 / ALCAM v pufru a ve zředěném lidském krevním séru pacientů s rakovinou a zdravými jedinci. Je ukázáno mmo jiné, že metoda SPR může rozlišit hladiny ALCAMu mezí pozitivními a negativními vzorky séra přímou detekcí bez nutnosti amplifikace. (cs)
- In this work, an ptimized SPR assay was implemented and its performance compared with an ELISA assay for CD166/activated cell leukocyte adhesion molecule (ALCAM), as candidate pancreatic cancer marker, based on direct and amplified detection in buffer and in human serum samples from healthy individuals and subjects with cancer. It is demonstrated that SPR can distinguish between ALCAM levels in cancer and control sera using direct detection without the need for additional amplification steps.
- In this work, an ptimized SPR assay was implemented and its performance compared with an ELISA assay for CD166/activated cell leukocyte adhesion molecule (ALCAM), as candidate pancreatic cancer marker, based on direct and amplified detection in buffer and in human serum samples from healthy individuals and subjects with cancer. It is demonstrated that SPR can distinguish between ALCAM levels in cancer and control sera using direct detection without the need for additional amplification steps. (en)
|
Title
| - Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera
- Srovnávací studie metod SPR a ELISA založená na analýze vzorků krevního séra pacientů s rakovinou a zdravých jedinců na přítomnost CD166/ALCAM (cs)
- Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera (en)
|
skos:prefLabel
| - Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera
- Srovnávací studie metod SPR a ELISA založená na analýze vzorků krevního séra pacientů s rakovinou a zdravých jedinců na přítomnost CD166/ALCAM (cs)
- Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera (en)
|
skos:notation
| - RIV/67985882:_____/09:00326027!RIV09-AV0-67985882
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/67985882:_____/09:00326027
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - SPR; ELISA; Cancer biomarkers (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Biosensors and Bioeletronics
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Jiang, S.
- Taylor, A. D.
- Vaisocherová, Hana
- Faca, V. M.
- Hanash, S.
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
is http://linked.open...avai/riv/vysledek
of | |